Lantheus to Present at the 2025 Truist Securities MedTech Conference

About this update from Lantheus Holdings, Inc.

BEDFORD, Mass. , June 10, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Brian Markison , Chief Executive Officer, will present at the 2025 Truist Securities MedTech Conference at 8:40 a.m. ET on Tuesday, June 17 . To access a live webcast of the presentation, please visit the Investors section of the Company’s website at www.lantheus.com . A replay of the webcast will be available on the Company’s website for at least 30 days following the live presentation. About Lantheus Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey , Canada , Sweden and Switzerland , Lantheus has been providing radiopharmaceutical solutions for nearly 70 years. For more information, visit www.lantheus.com . Contacts: Mark Kinarney Vice President, Investor Relations978-671-8842 [email protected] Melissa Downs Executive Director, External Communications 646-975-2533 [email protected] Source: Lantheus Holdings, Inc.

View stock analysis, news, and events for Lantheus Holdings, Inc.